50 Participants Needed

SRW Cel System for Healthy Aging

No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

What is the purpose of this trial?

This trial tests the Cel System protocol, which includes three formulas and an app for healthy lifestyle changes, on people interested in healthy aging. It aims to see how well this combination can affect biological aging markers and overall health.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot use prescription immunomodulating products (like glucocorticoids) in the month before the trial starts. Also, starting new medications during the trial that might interfere with the study is not allowed.

What makes the SRW Cel System treatment unique for healthy aging?

The SRW Cel System treatment is unique because it focuses on optimizing the body's circadian rhythms (the natural internal process that regulates the sleep-wake cycle) and sleep patterns, which are crucial for healthy aging. Unlike other treatments that may target specific symptoms, this approach aims to enhance overall physiological balance and prevent age-related disruptions in bodily systems.12345

Eligibility Criteria

This trial is for individuals aged 55 or older who are post-menopausal (if female), can follow the treatment plan, and have a smartphone to use an app. They must be able to read and speak English, consume supplements during the study, and not have any major health issues that could affect participation.

Inclusion Criteria

Participant must have a smartphone and be able to download and use the App
55 years and older
Participant must have an established primary care provider
See 5 more

Exclusion Criteria

Planned surgical procedure during study period
Any person deemed by the Investigator as having a low likelihood of complying with study protocol (e.g. evidence of history of non-compliance, history of poor follow-up, multiple or complex scheduling conflicts)
Participants who are actively engaged in a weight loss program or have started any new medications during the duration of the trial that can potentially interfere with the study, as deemed appropriate by Principal Investigator.
See 11 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants take the Cel System protocol supplements daily to target the 9 Hallmarks of Aging

12 months
Monthly visits for sample collection

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • SRW Cel System
Trial OverviewThe SRW Cel System protocol targets all nine hallmarks of aging with three formulas combined with a lifestyle app. The goal is to see if this approach supports healthy aging by impacting these key biological factors.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: SRW Cel systemExperimental Treatment1 Intervention
Cel1, Cel2, Cel3 Patients will take all three supplements once daily. Patients will take 2 capsules of each supplement in the morning with food.

Find a Clinic Near You

Who Is Running the Clinical Trial?

TruDiagnostic

Lead Sponsor

Trials
12
Recruited
490+
Founded
2019
Headquarters
Lexington, United States
Known For
Epigenetic testing

SRW

Collaborator

Trials
1
Recruited
50+

References

Circadian and homeostatic modulation of sleep in older adults during a 90-minute day study. [2019]
2.United Arab Emiratespubmed.ncbi.nlm.nih.gov
Principal component structuring of the non-REM Sleep EEG spectrum in older adults yields age-related changes in the sleep and wake drives. [2019]
Sample entropy tracks changes in electroencephalogram power spectrum with sleep state and aging. [2022]
Senescence, sleep, and circadian rhythms. [2021]
Aging in the circadian system: considerations for health, disease prevention and longevity. [2022]